SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1op2'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1AQ7_B_AG2B4_1
(TRYPSIN
AERUGINOSIN 98-B)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 8 HIS A  57
ASP A 189
SER A 195
VAL A 213
GLY A 216
GLY A 226
 None
 0.66A 1aq7A-1op2A:
33.8		 1aq7A-1op2A:
41.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1BCU_H_PRLH280_0
(ALPHA-THROMBIN)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		5 / 9 ASP A 189
SER A 195
VAL A 213
GLY A 216
GLY A 226
 None
 0.23A 1bcuH-1op2A:
16.4		 1bcuH-1op2A:
32.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ETR_H_MITH1_1
(EPSILON-THROMBIN)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 HIS A  57
ASP A 189
SER A 195
VAL A 213
GLY A 216
GLY A 226
 None
 0.57A 1etrH-1op2A:
31.2		 1etrH-1op2A:
33.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1F5L_A_AMRA301_1
(UROKINASE-TYPE
PLASMINOGEN
ACTIVATOR)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		5 / 8 ASP A 189
SER A 195
VAL A 213
GLY A 216
GLY A 226
 None
 0.44A 1f5lA-1op2A:
10.4		 1f5lA-1op2A:
31.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1TNL_A_TPAA900_1
(TRYPSIN)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		5 / 6 ASP A 189
SER A 195
VAL A 213
GLY A 216
GLY A 226
 None
 0.48A 1tnlA-1op2A:
34.5		 1tnlA-1op2A:
41.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2D55_C_DVAC2_0
(ACTINOMYCIN D)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		3 / 3 THR A 245
PRO A 245
PRO A  92
 None
 0.78A 2d55C-1op2A:
undetectable		 2d55C-1op2A:
4.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DPM_A_SAMA300_0
(PROTEIN
(ADENINE-SPECIFIC
METHYLTRANSFERASE
DPNII 1))		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		5 / 12 PHE A  40
GLY A 193
GLY A 192
PHE A  33
PHE A  34
 None
 1.12A 2dpmA-1op2A:
undetectable		 2dpmA-1op2A:
21.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2OTV_A_NCAA1301_0
(CATIONIC TRYPSIN)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		5 / 6 ASP A 189
SER A 195
VAL A 213
GLY A 216
GLY A 226
 None
 0.33A 2otvA-1op2A:
34.8		 2otvA-1op2A:
41.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2P16_A_GG2A298_1
(COAGULATION FACTOR X
(EC 3.4.21.6)
(STUART FACTOR)
(STUART-PROWER
FACTOR))		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 ASP A 189
SER A 195
VAL A 213
GLY A 216
GLY A 226
TYR A 228
 None
 0.35A 2p16A-1op2A:
11.9		 2p16A-1op2A:
28.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PXC_A_SAMA500_0
(GENOME POLYPROTEIN
[CONTAINS: CAPSID
PROTEIN C (CORE
PROTEIN)
ENVELOPE PROTEIN M
(MATRIX PROTEIN)
MAJOR ENVELOPE
PROTEIN E
NON-STRUCTURAL
PROTEIN 1 (NS1)
NON-STRUCTURAL
PROTEIN 2A (NS2A)
FLAVIVIRIN PROTEASE
NS2B REGULATORY
SUBUNIT
FLAVIVIRIN PROTEASE
NS3 CATALYTIC
SUBUNIT
NON-STRUCTURAL
PROTEIN 4A (NS4A)
NON-STRUCTURAL
PROTEIN 4B (NS4B)
RNA-DIRECTED RNA
POLYMERASE (EC
2.7.7.48) (NS5)])		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 GLY A 142
GLY A  44
GLY A 196
GLY A 193
THR A  54
VAL A  52
 None
 1.36A 2pxcA-1op2A:
undetectable		 2pxcA-1op2A:
18.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2VIN_A_505A1247_1
(UROKINASE-TYPE
PLASMINOGEN
ACTIVATOR CHAIN B)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		5 / 8 ASP A 189
SER A 195
VAL A 213
GLY A 216
GLY A 226
 None
 0.55A 2vinA-1op2A:
9.2		 2vinA-1op2A:
31.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W26_A_RIVA1001_1
(ACTIVATED FACTOR XA
HEAVY CHAIN)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 ASP A 189
SER A 195
VAL A 213
GLY A 216
GLY A 226
TYR A 228
 None
 0.23A 2w26A-1op2A:
10.9		 2w26A-1op2A:
28.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ELW_A_SAMA4633_0
(METHYLTRANSFERASE)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 GLY A 142
GLY A  44
GLY A 196
GLY A 193
THR A  54
VAL A  52
 None
 1.43A 3elwA-1op2A:
undetectable		 3elwA-1op2A:
19.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GY3_A_PNTA246_0
(CATIONIC TRYPSIN)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		5 / 11 HIS A  57
ASP A 189
SER A 195
GLY A 216
GLY A 226
 None
 0.53A 3gy3A-1op2A:
33.2		 3gy3A-1op2A:
41.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NVK_I_SAMI228_0
(FIBRILLARIN-LIKE
RRNA/TRNA
2'-O-METHYLTRANSFERA
SE)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		5 / 12 LYS A  16
GLY A 197
ILE A 212
ALA A  55
ASP A 194
 None
 1.07A 3nvkI-1op2A:
undetectable		 3nvkI-1op2A:
21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3P97_C_SAMC263_0
(NON-STRUCTURAL
PROTEIN 5)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 GLY A 142
GLY A  44
GLY A 196
GLY A 193
THR A  54
VAL A  52
 None
 1.29A 3p97C-1op2A:
undetectable		 3p97C-1op2A:
18.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RXF_A_4APA9_1
(CATIONIC TRYPSIN)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		4 / 6 SER A 195
VAL A 213
GLY A 216
GLY A 226
 None
 0.38A 3rxfA-1op2A:
14.4		 3rxfA-1op2A:
41.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RXH_A_HSMA7_1
(CATIONIC TRYPSIN)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		4 / 5 ASP A 189
SER A 195
VAL A 213
GLY A 226
 None
 0.39A 3rxhA-1op2A:
34.4		 3rxhA-1op2A:
41.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S43_A_478A401_1
(PROTEASE)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		5 / 9 ALA A 183
ILE A 138
VAL A 213
GLY A 216
ILE A 160
 None
 0.98A 3s43A-1op2A:
undetectable		 3s43A-1op2A:
18.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TNE_B_RITB401_2
(SECRETED ASPARTIC
PROTEASE)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		4 / 7 SER A 195
THR A 229
THR A 180
TYR A 234
 None
 0.86A 3tneB-1op2A:
undetectable		 3tneB-1op2A:
21.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AC9_C_DXCC1475_0
(MJ0495-LIKE PROTEIN)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		4 / 8 ILE A 103
ASP A 102
ILE A 212
GLY A  44
 None
 0.85A 4ac9C-1op2A:
undetectable		 4ac9C-1op2A:
18.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AC9_C_DXCC1478_0
(MJ0495-LIKE PROTEIN)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		4 / 7 ASP A 194
GLY A  44
THR A  45
THR A 190
 None
 0.87A 4ac9C-1op2A:
undetectable		 4ac9C-1op2A:
18.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ACA_C_DXCC1478_0
(TRANSLATION
ELONGATION FACTOR
SELB)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		4 / 7 ASP A 194
GLY A  44
THR A  45
THR A 190
 None
 0.87A 4acaC-1op2A:
undetectable		 4acaC-1op2A:
18.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTJ_A_SAMA1263_0
(NON-STRUCTURAL
PROTEIN 5)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 GLY A 142
GLY A  44
GLY A 196
GLY A 193
THR A  54
VAL A  52
 None
 1.28A 4ctjA-1op2A:
undetectable		 4ctjA-1op2A:
18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTJ_C_SAMC1263_0
(NON-STRUCTURAL
PROTEIN 5)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 GLY A 142
GLY A  44
GLY A 196
GLY A 193
THR A  54
VAL A  52
 None
 1.28A 4ctjC-1op2A:
undetectable		 4ctjC-1op2A:
18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTK_A_SAMA1263_0
(POLYPROTEIN)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 GLY A 142
GLY A  44
GLY A 196
GLY A 193
THR A  54
VAL A  52
 None
 1.31A 4ctkA-1op2A:
undetectable		 4ctkA-1op2A:
18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTK_C_SAMC1263_0
(POLYPROTEIN)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 GLY A 142
GLY A  44
GLY A 196
GLY A 193
THR A  54
VAL A  52
 None
 1.28A 4ctkC-1op2A:
undetectable		 4ctkC-1op2A:
18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FGL_C_CLQC303_1
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		4 / 8 GLY A  44
VAL A  31
PHE A 209
ILE A  47
 None
 0.72A 4fglD-1op2A:
undetectable		 4fglD-1op2A:
22.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FGL_D_CLQD303_0
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		4 / 7 GLY A  44
VAL A  31
PHE A 209
ILE A  47
 None
 0.71A 4fglC-1op2A:
undetectable		 4fglC-1op2A:
22.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OBW_C_SAMC601_0
(2-METHOXY-6-POLYPREN
YL-1,4-BENZOQUINOL
METHYLASE,
MITOCHONDRIAL)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		5 / 12 GLY A  18
ILE A 185
GLY A 184
ARG A 137
ASN A 159
 None
 1.20A 4obwC-1op2A:
undetectable		 4obwC-1op2A:
21.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PD9_A_ADNA501_2
(NUPC FAMILY PROTEIN)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		3 / 3 THR A  45
ASN A 230
PHE A 232
 None
 0.62A 4pd9A-1op2A:
undetectable		 4pd9A-1op2A:
19.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_1
(BETA-LACTOGLOBULIN)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		3 / 3 LYS A 110
ILE A 112
ILE A 118
 None
 0.62A 4y0qA-1op2A:
undetectable		 4y0qA-1op2A:
18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5E9Q_A_SAMA301_0
(GENOME POLYPROTEIN)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 GLY A 142
GLY A  44
GLY A 196
GLY A 193
THR A  54
VAL A  52
 None
 1.30A 5e9qA-1op2A:
undetectable		 5e9qA-1op2A:
19.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5E9Q_C_SAMC4000_0
(GENOME POLYPROTEIN)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 GLY A 142
GLY A  44
GLY A 196
GLY A 193
THR A  54
VAL A  52
 None
 1.30A 5e9qC-1op2A:
undetectable		 5e9qC-1op2A:
19.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EC8_C_SAMC4000_0
(GENOME POLYPROTEIN)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 GLY A 142
GLY A  44
GLY A 196
GLY A 193
THR A  54
VAL A  52
 None
 1.28A 5ec8C-1op2A:
undetectable		 5ec8C-1op2A:
18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EHG_A_SAMA301_0
(RNA-DIRECTED RNA
POLYMERASE NS5)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 GLY A 142
GLY A  44
GLY A 196
GLY A 193
THR A  54
VAL A  52
 None
 1.30A 5ehgA-1op2A:
undetectable		 5ehgA-1op2A:
18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EHG_C_SAMC4001_0
(RNA-DIRECTED RNA
POLYMERASE NS5)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 GLY A 142
GLY A  44
GLY A 196
GLY A 193
THR A  54
VAL A  52
 None
 1.29A 5ehgC-1op2A:
undetectable		 5ehgC-1op2A:
18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EIF_A_SAMA301_0
(GENOME POLYPROTEIN)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 GLY A 142
GLY A  44
GLY A 196
GLY A 193
THR A  54
VAL A  52
 None
 1.29A 5eifA-1op2A:
undetectable		 5eifA-1op2A:
18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EIF_C_SAMC4000_0
(GENOME POLYPROTEIN)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 GLY A 142
GLY A  44
GLY A 196
GLY A 193
THR A  54
VAL A  52
 None
 1.28A 5eifC-1op2A:
undetectable		 5eifC-1op2A:
18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EIW_C_SAMC4000_0
(NS5
METHYLTRANSFERASE)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 GLY A 142
GLY A  44
GLY A 196
GLY A 193
THR A  54
VAL A  52
 None
 1.27A 5eiwC-1op2A:
undetectable		 5eiwC-1op2A:
18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EKX_B_SAMB4000_0
(NS5
METHYLTRANSFERASE)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 GLY A 142
GLY A  44
GLY A 196
GLY A 193
THR A  54
VAL A  52
 None
 1.28A 5ekxB-1op2A:
undetectable		 5ekxB-1op2A:
18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KQR_A_SAMA301_0
(METHYLTRANSFERASE)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 GLY A 142
GLY A  44
GLY A 196
GLY A 193
THR A  54
VAL A  52
 None
 1.31A 5kqrA-1op2A:
undetectable		 5kqrA-1op2A:
19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L1F_A_6ZPA902_1
(GLUTAMATE RECEPTOR 2)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		4 / 8 SER A 127
PRO A 129
SER A 122
SER A 134
 None
 1.04A 5l1fA-1op2A:
undetectable
5l1fB-1op2A:
undetectable		 5l1fA-1op2A:
15.37
5l1fB-1op2A:
15.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M5B_A_SAMA1001_0
(NS5
METHYLTRANSFERASE)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 GLY A 142
GLY A  44
GLY A 196
GLY A 193
THR A  54
VAL A  52
 None
 1.28A 5m5bA-1op2A:
undetectable		 5m5bA-1op2A:
19.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NJV_A_SAMA301_0
(NS5)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 GLY A 142
GLY A  44
GLY A 196
GLY A 193
THR A  54
VAL A  52
 None
 1.29A 5njvA-1op2A:
undetectable		 5njvA-1op2A:
19.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NJV_B_SAMB301_0
(NS5)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 GLY A 142
GLY A  44
GLY A 196
GLY A 193
THR A  54
VAL A  52
 None
 1.30A 5njvB-1op2A:
undetectable		 5njvB-1op2A:
19.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5W7B_B_PA1B204_1
(ACYLOXYACYL
HYDROLASE SMALL
SUBUNIT
ACYLOXYACYL
HYDROLASE LARGE
SUBUNIT)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		3 / 3 GLY A  19
ASN A  20
ARG A 137
 None
 0.75A 5w7bD-1op2A:
undetectable		 5w7bD-1op2A:
16.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WZ1_B_SAMB601_0
(NS5
METHYLTRANSFERASE)		 1op2 VENOM SERINE
PROTEINASE
(Deinagkistrodon
acutus) 		6 / 12 GLY A 142
GLY A  44
GLY A 196
GLY A 193
THR A  54
VAL A  52
 None
 1.34A 5wz1B-1op2A:
0.0		 5wz1B-1op2A:
18.88